H2 receptor antagonists vs placebo
Leaving the study early · people with schizophrenia with antipsychotic‐induced weight gain
H2 antagonists showed no clear difference in leaving the study early: for any reason compared with placebo (low certainty).
1 finding from 1 review
- Pharmacological interventions for prevention of weight gain in people with schizophrenia 2022 · Cochrane Headline outcomes onlyRR 1.07 [0.72, 1.57]2 studies · 189 participantsLow